Top Markets
#1 Status Status +19.17%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.58%
#3 GoPlus Security GoPlus Security +16.92%
#4 Wrapped NXM Wrapped NXM +15.13%
#5 Ontology Gas Ontology Gas +11.65%
#6 DMT-NAT DMT-NAT +8.98%
#7 Pons Pons +8.13%
#8 Nesa Nesa +7.39%
#9 Janction Janction +7.01%
#10 Nillion Nillion +6.56%
Coin of the day
Status Status
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
TruScreen Group Limited TruScreen Group Limited

TruScreen Group Limited

TRU
Clasificación en acciones #34030
TruScreen Group Limited, alongside its subsidiaries, focuses on the... TruScreen Group Limited, alongside its subsidiaries, focuses on the development, manufacturing, and global distribution of advanced systems for cancer detection. Their commercial reach extends across various international territories, including Mexico, China, Russia, Vietnam, Zimbabwe, countries within Eastern Europe, the Middle East/North Africa region, and beyond. A flagship product is the TruScreen cervical cancer screening system, a specialized medical device engineered to provide real-time identification of precancerous and cancerous tissue present on the cervix. Established in 2013, the company, with its primary base of operations in Auckland, New Zealand, officially changed its name from TruScreen Limited to Truscreen Group Limited in August 2020.
Precio por acción
$0.00903546
Capitalización bursátil
$6.38M
Cambio (1 día)
0.00%
Cambio (1 año)
-15.28%
País
NZ
Comercio TruScreen Group Limited (TRU)

Categoría

Healthcare
Ganancias de TruScreen Group Limited (TRU)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di TruScreen Group Limited, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de TruScreen Group Limited desde 2026 hasta 2026
Ganancias al final de cada año
Año Ganancias Cambiar
Not enough data for the provided dates.
Ganancias de empresas similares o competidoras
Empresa Ganancias Diferencia de ganancias País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
$7.51B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
$5.15B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
$5.56B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
$3.86B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
$1.42B -
US